(Q37274726)
Statements
Prospective comparison of the clinical impacts of heterogeneous vancomycin-intermediate methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-susceptible MRSA (English)
K C Horne
E A Grabsch
M Graham
P B Ward
S Xie
B C Mayall
P D R Johnson